Moe SM, Drueke T: Improving global outcomes in mineral and bone disorders. Clinical journal of the American Society of Nephrology : CJASN. 2008, 3 (Suppl 3): S127-S130.
Article
PubMed
PubMed Central
Google Scholar
Ruggenenti P, Perna A, Remuzzi G: Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int. 2003, 63 (6): 2254-2261. 10.1046/j.1523-1755.2003.00033.x.
Article
CAS
PubMed
Google Scholar
Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, et al: Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2009, 54 (2): 205-226. 10.1053/j.ajkd.2009.04.029.
Article
Google Scholar
Boner G, Cooper ME, McCarroll K, Brenner BM, de Zeeuw D, Kowey PR, et al: Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia. 2005, 48 (10): 1980-1987.
Article
CAS
PubMed
Google Scholar
Remuzzi G, Chiurchiu C, Ruggenenti P: Proteinuria predicting outcome in renal disease: nondiabetic nephropathies (REIN). Kidney Int Suppl. 2004, 92: S90-S96.
Article
CAS
PubMed
Google Scholar
Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, et al: Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005, 68 (6): 2823-2828. 10.1111/j.1523-1755.2005.00755.x.
Article
CAS
PubMed
Google Scholar
Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, et al: Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008, 52 (2): 249-255. 10.1161/HYPERTENSIONAHA.108.113159.
Article
CAS
PubMed
Google Scholar
Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N: Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2009, 54 (4): 647-652. 10.1053/j.ajkd.2009.04.036.
Article
CAS
Google Scholar
de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al: Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010, 376 (9752): 1543-1551. 10.1016/S0140-6736(10)61032-X.
Article
CAS
PubMed
Google Scholar
Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY: Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2012, 59 (1): 67-74. 10.1053/j.ajkd.2011.09.014.
Article
CAS
Google Scholar
Reichel H: Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease. Nephron Clin Pract. 2010, 114 (4): c268-c276. 10.1159/000276579.
Article
CAS
PubMed
Google Scholar
Hansen D, Rasmussen K, Danielsen H, Meyer-Hofmann H, Bacevicius E, Lauridsen TG, et al: No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial. Kidney Int. 2011, 80 (8): 841-850. 10.1038/ki.2011.226.
Article
CAS
PubMed
Google Scholar
Matthias S, Busch R, Merke J, Mall G, Thomasset M, Ritz E: Effects of 1,25(OH)2D3 on compensatory renal growth in the growing rat. Kidney Int. 1991, 40 (2): 212-218. 10.1038/ki.1991.202.
Article
CAS
PubMed
Google Scholar
Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E: Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998, 53 (6): 1696-1705. 10.1046/j.1523-1755.1998.00951.x.
Article
CAS
PubMed
Google Scholar
Panichi V, Migliori M, Taccola D, Filippi C, De Nisco L, Giovannini L, et al: Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int. 2001, 60 (1): 87-95. 10.1046/j.1523-1755.2001.00775.x.
Article
CAS
PubMed
Google Scholar
Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, et al: A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol. 2001, 158 (5): 1733-1741. 10.1016/S0002-9440(10)64129-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, et al: 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004, 286 (3): F526-F533. 10.1152/ajprenal.00316.2003.
Article
CAS
PubMed
Google Scholar
Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, et al: Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. Journal of the American Society of Nephrology : JASN. 2007, 18 (6): 1796-1806. 10.1681/ASN.2006091028.
Article
CAS
PubMed
Google Scholar
Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, et al: Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2008, 73 (2): 163-171. 10.1038/sj.ki.5002572.
Article
CAS
PubMed
Google Scholar
Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC: Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA. 2008, 105 (41): 15896-15901. 10.1073/pnas.0803751105.
Article
CAS
PubMed
PubMed Central
Google Scholar
Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, et al: Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008, 74 (11): 1394-1402. 10.1038/ki.2008.408.
Article
CAS
PubMed
Google Scholar
Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, et al: Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009, 297 (3): F791-F801. 10.1152/ajprenal.00247.2009.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, et al: Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2009, 24 (8): 2354-2361. 10.1093/ndt/gfp117.
Article
CAS
Google Scholar
Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, et al: Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int. 2010, 77 (11): 1000-1009. 10.1038/ki.2010.22.
Article
CAS
PubMed
Google Scholar
Ohara I, Tanimoto M, Gohda T, Yamazaki T, Hagiwara S, Murakoshi M, et al: Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice. Nephron Exp Nephrol. 2011, 117 (4): e124-e132. 10.1159/000320284.
Article
CAS
PubMed
Google Scholar
Lydia A, Asanuma K, Nonaka K, Takagi M, Jeong KH, Kodama F, et al: Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis. Am J Nephrol. 2012, 35 (1): 58-68. 10.1159/000334626.
Article
CAS
PubMed
Google Scholar
Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, Glenn DJ, et al: Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. Am J Physiol Renal Physiol. 2012, 302 (1): F141-F149. 10.1152/ajprenal.00293.2011.
Article
CAS
PubMed
Google Scholar
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110 (2): 229-238.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tan X, Li Y, Liu Y: Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. Journal of the American Society of Nephrology : JASN. 2006, 17 (12): 3382-3393. 10.1681/ASN.2006050520.
Article
CAS
PubMed
Google Scholar
Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK: Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2008, 51 (5): 724-731. 10.1053/j.ajkd.2007.12.038.
Article
CAS
Google Scholar
McMurray J, Abraham W, Dickstein T, Køber L, Massie B, Krum AH: ALTITUDE and the implications for ATMOSPHERE. Eur J Heart Fail. 2012, 14 (4): 341-343. 10.1093/eurjhf/hfs033.
Article
PubMed
PubMed Central
Google Scholar